Image Results

Carcinoid Tumor Reports From BioPortfolio:

Market Research Reports / Management Reports / Research Reports

BioPortfolio Limited The Drug Target Atlas of Apoptopic Drugs in ...
Table 24: Apoptopic Drug Target Mix for the Treatment of Carcinoid Tumor According to the Compound Type and Developmental Stage of Drug .......... 197
...
http://www.bioportfolio.com/cgi-bin/acatalog/info_302.html...

Table of Contents
MBD2 inhibition identified as a selective strategy for reducing tumor growth ...... cgi-bin/acatalog/Retail Clinics The Emerging Market for Convenience and
...... New Treatment Approaches Proving Valuable against Carcinoid Syndrome ...
http://www.bioportfolio.com/tableof.htm...

Results from other life science and pharmaceutical sites:

Learn more about - Carcinoid Tumors Novartis Pharmaceuticals
Information and online resources for Carcinoid Tumors available from Novartis ... Novartis is recognized worldwide for bringing to market innovative ...
http://www.pharma.us.novartis.com/diseases-conditions/carcin...

Priorities for Improving the Management of Gastroenteropancreatic ...
This report delineates the main conclusions of the meeting, ..... Two rodent models of gastrointestinal carcinoid tumors have been described (34,35). ....
tumor disease, the amount of basic and translational research in this field is
very ... which are companies that market a somatostatin receptor analog for the
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2538549/...

Novartis products in development
Novartis Institutes for BioMedical Research (NIBR) ... There can be no guarantee that any new products will be approved for sale in any market, or that any new
... Afinitor® Carcinoid tumors. SBR759 Hyperphosphatemia. PKC412 ASM6 ...
http://www.novartis.com/research/pharmaceutical-product.shtm...

OCHSNER HEALTH SYSTEM 2008 ANNUAL REPORT
President People Technology Academics Clinical Outreach Market Update .... 2008 Annual Report. LEADERSHIP: ACADEMICS. Research is another major area of critical
.... of its nationally recognized Neuroendocrine (Carcinoid) Tumor Program, ...
http://www.ochsner.org/sa/ar08/OHS6966_Mab_08AnnReport_pg18....

New study first to confirm Sandostatin® LAR® controls tumor growth ...
14 Jan 2009 ... Novartis Institutes for BioMedical Research (NIBR) ... and the nervous system, and includes carcinoid tumors and pancreatic NETs. ... be submitted or approved
for any additional indications or labeling in any market. ...
http://www.novartis.com/newsroom/media-releases/en/2009/1281...

Business & Regulatory Report
Rare post-marketing reports of anaphylactic shock and angioedema have been reported. Clinical Trials: ... in patients with metastatic carcinoid tumors.
Elevated .... for clinical research for US Oncology and co-director of ...
http://www.bcm.edu/cancercenter/?PMID=12379...

Roche Annual Report 2008 - Pharmaceuticals and Diagnostics pipelines
tember enables Roche to further advance its research in the field of ribonucleic acid interference ... new marketing applications and gained 13 major regulatory
approvals. .... solid tumors. I. Genentech a R7334 anti-PlGF huMAb solid tumors.
I. ThromboGenics/ .... anti-VEGF monoclonal antibody high risk carcinoid ...
http://www.roche.com/gb08erd.pdf...

LX1032
The target for LX1032 is TPH, the rate-limiting enzyme involved in serotonin biosynthesis and present in metastatic carcinoid tumor cells. From research ...
http://www.lexgen.com/pipeline/lx1032.html...

SEER: Critical Public Health Program
Surgeon General's Report; Rare Cancers; Health Disparities. Cancer Etiology ... Neuroendocrine/carcinoid Tumors: A Growing Problem ... Research breadth
facilitated by linking SEER's core data to other population-based data sources:
... Other opportunities for post-marketing surveillance? Your Feedback ...
http://deainfo.nci.nih.gov/advisory/bsa/bsa1108/presentation...

Glivec receives FDA priority review as first therapy to reduce ...
27 Aug 2008 ... Novartis Institutes for BioMedical Research (NIBR) ... Novartis also has a therapy for the treatment for carcinoid tumors .... There can be no guarantee
that Glivec will be approved for any additional indications or labelling in any
market. ... Imatinib for Gastrointestinal Stromal Tumors (GISTs). ...
http://www.novartis.com/newsroom/media-releases/en/2008/1246...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.